Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
Giulio Marchesini, Salvatore Petta, Riccardo Dalle Grave
Hepatology (2015) Vol. 63, Iss. 6, pp. 2032-2043
Open Access | Times Cited: 275

Showing 1-25 of 275 citing articles:

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 732
Non-alcoholic fatty liver disease and dyslipidemia: An update
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros
Metabolism (2016) Vol. 65, Iss. 8, pp. 1109-1123
Closed Access | Times Cited: 493
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
Ryuki Hashida, Takumi Kawaguchi, Masafumi Bekki, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 1, pp. 142-152
Closed Access | Times Cited: 411
Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities
Justin D. Smith, Emily Fu, Marissa A. Kobayashi
Annual Review of Clinical Psychology (2020) Vol. 16, Iss. 1, pp. 351-378
Open Access | Times Cited: 312
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, et al.
Digestive and Liver Disease (2017) Vol. 49, Iss. 5, pp. 471-483
Open Access | Times Cited: 288
Complications of obesity
David Kinlen, Declan Cody, Donal O’Shea
QJM (2017) Vol. 111, Iss. 7, pp. 437-443
Open Access | Times Cited: 254
Current treatment paradigms and emerging therapies for NAFLD/NASH
Sana Raza, Sangam Rajak, Aditya Upadhyay, et al.
Frontiers in bioscience (2020) Vol. 26, Iss. 2, pp. 206-237
Open Access | Times Cited: 247
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva, Anastasia Teterina, Elena M. Comelli, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 236
Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
Christina N. Katsagoni, Michael Georgoulis, George Papatheodoridis, et al.
Metabolism (2016) Vol. 68, pp. 119-132
Closed Access | Times Cited: 235
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Henrik H. Hansen, Michael Feigh, Sanne Skovgård Veidal, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 11, pp. 1707-1718
Open Access | Times Cited: 217
Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway
Xiaojuan Zhao, Hanwen Yu, Yan‐Zi Yang, et al.
Redox Biology (2018) Vol. 18, pp. 124-137
Open Access | Times Cited: 217
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 205
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada
Nutrients (2019) Vol. 11, Iss. 3, pp. 677-677
Open Access | Times Cited: 188
Towards a multidisciplinary approach to understand and manage obesity and related diseases
Stephan C. Bischoff, Yves Boirie‌, Tommy Cederholm, et al.
Clinical Nutrition (2016) Vol. 36, Iss. 4, pp. 917-938
Open Access | Times Cited: 178
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study
Marcin Krawczyk, Monika Rau, Jörn M. Schattenberg, et al.
Journal of Lipid Research (2016) Vol. 58, Iss. 1, pp. 247-255
Open Access | Times Cited: 177
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello, Antonino Di Pino, Roberto Scicali, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1948-1948
Open Access | Times Cited: 170
Treatments for NAFLD: State of Art
Alessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2350-2350
Open Access | Times Cited: 161
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
Carmelo Luci, Manon Bourinet, Pierre Leclère, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 147
Management of non-alcoholic fatty liver disease
Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, et al.
BMJ (2021), pp. m4747-m4747
Open Access | Times Cited: 147
Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks
Lee Crosby, Brenda Davis, Shivam Joshi, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 147
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 136
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 29
Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
Angelo Armandi, Elisabetta Bugianesi
European Journal of Internal Medicine (2024) Vol. 122, pp. 20-27
Closed Access | Times Cited: 18
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025) Vol. 14, pp. 100164-100164
Open Access | Times Cited: 2
The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups
Shiv Chitturi, Vincent Wai‐Sun Wong, Wah‐Kheong Chan, et al.
Journal of Gastroenterology and Hepatology (2017) Vol. 33, Iss. 1, pp. 86-98
Open Access | Times Cited: 154
Page 1 - Next Page

Scroll to top